Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Ondas Holdings Inc. Announces Closing of $1 Billion Offering
-
Dogwood Therapeutics raises $12.5 million in registered direct offering
-
Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development
-
Rubico prices $4 million public offering at $0.60 per unit
-
Rubico Announces Pricing of $4.0 Million Public Offering
-
Ondas Holdings prices $1 billion stock and warrant offering at premium
-
Ondas Holdings Inc. Successfully Prices $1 Billion Stock and Warrant Sale Above Market Price
-
AmpliTech Group adds Tommaso Melodia to advisory board
-
AmpliTech Group Appoints Professor Tommaso Melodia To Its Board of Advisors to Support Strategic Growth Across ORAN Architectures and AI-native Wireless Networks
-
Maxim Group Starts Herbalife (HLF) at Buy
-
Open World and VerifyMe plan merger to list on NASDAQ
-
Token Economy Leader Open World and VerifyMe Announce Plans to List on Nasdaq via Proposed Strategic Merger
-
Maxim Group Starts Titan Mining Corp. (TII) at Buy
-
Medicus Pharma establishes $15.3 million at-the-market equity program
-
IMUNON raises $7 million in registered direct offering
-
IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
-
Nouveau Monde Graphite completes $20 million share offering
-
NMG Announces Closing of US$20 Million Public Offering of Common Shares
-
LM Funding America prices $6.5 million registered direct offering
-
LM Funding America Announces Pricing of Registered Direct Offering for Aggregate Gross Proceeds of $6.5 Million
-
Titan Mining Closes US$15 Million Institutional Financing to Advance U.S. Graphite Strategy
-
AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
-
Biodexa prices $10 million public offering at $3.28 per unit
-
Biodexa prices $10 million public offering at $3.28 per unit
-
Biodexa Announces Pricing of $10 Million Public Offering
-
Biodexa Announces Pricing of $10 Million Public Offering
-
Maxim Group Downgrades Two Harbors Investment (TWO) to Hold
-
Nouveau Monde Graphite prices $20 million equity offering at $2.40 per share
-
NMG Announces Pricing of US$20 Million Public Equity Offering
-
Nouveau Monde Graphite announces overnight public stock offering
-
NMG Announces Overnight Marketed Public Offering
-
Maxim Group Downgrades VistaGen Therapeutics (VTGN) to Hold
-
Titan Mining secures $15 million investment for New York graphite project
-
Titan Mining Announces US$15 Million Investment from a leading Institutional Investor to Accelerate U.S Graphite Development in New York
-
Alpha Modus files to register 11.3 million shares for resale
-
D. Boral Capital Expands Leadership Team with New Partners
-
Iconix Brand (ICON) PT Lowered to $2 at Maxim Group
-
Moleculin raises $6.5 million through warrant exercises
-
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
-
Maxim Group Starts Strive Enterprises, Inc. (ASST) at Buy
-
Maxim Group LLC Announces Appointment of Kelsey Vinson Pols to Support Expansion of M&A Practice and West Coast Presence
-
Maxim Group LLC Announces Appointment of Kelsey Vinson Pols to Support Expansion of M&A Practice and West Coast Presence
-
Aprea Therapeutics raises $3.1 million in private placement
-
Aprea Therapeutics Announces $3.1 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Angel Studios establishes $150 million at-the-market equity offering program
-
Medicus Pharma enters $5.1 million warrant inducement agreement
-
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
-
Aethlon Medical raises $3.3 million through private placement
-
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
-
InvestorNewsBreaks – Belite Bio, Inc (NASDAQ: BLTE) Prices $350M Underwritten Public Offering of ADSs

